Front. Med. Frontiers in Medicine Front. Med. 2296-858X Frontiers Media S.A. 10.3389/fmed.2021.785148 Medicine Correction Corrigendum: Development and Characterization of a New Endoscopic Drug-Eluting Platform With Proven Efficacy in Acute and Chronic Experimental Colitis Bon Ignacio 1 Cano-Sarabia Mary 2 de la Ossa Napoleon 3 Bartolí Ramon 1 4 * † Lorenzo-Zúñiga Vicente 1 5 * † 1Health Research Institute Germans Trias i Pujol (IGTP), Barcelona, Spain 2Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and The Barcelona Institute of Science and Technology, Campus de la UAB, Bellaterra, Spain 3Servicio de Anatomia Patológica, Hospital Universitari General de Catalunya—Grupo Quirón Salud, Barcelona, Spain 4Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain 5Endoscopy Unit, University Hospital La Fe, Valencia, Spain *Correspondence: Ramon Bartolí rbartolisole@gmail.com Vicente Lorenzo-Zúñiga vlorenzozuniga@gmail.com

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

This article was submitted to Gastroenterology, a section of the journal Frontiers in Medicine

†These authors have contributed equally to this work

 26 10 2021 2021 8 785148 28 09 2021 05 10 2021 Copyright © 2021 Bon, Cano-Sarabia, de la Ossa, Bartolí and Lorenzo-Zúñiga. 2021 Bon, Cano-Sarabia, de la Ossa, Bartolí and Lorenzo-Zúñiga

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Development and Characterization of a New Endoscopic Drug-Eluting Platform With Proven Efficacy in Acute and Chronic Experimental Colitis by Bon, I., Cano-Sarabia, M., de la Ossa, N., Bartolí, R., and Lorenzo-Zúñiga, V. (2020). Front. Med. 7:415. doi: 10.3389/fmed.2020.00415 drug-eluting experimental colitis endoscopic shielding technique hydrogel endoscopy

There is an error in the Funding statement. Instead of “Health Institute carlos III”, the correct name for the funder is “Instituto de Salud Carlos III (Co-funded by European Regional Development Fund/European Social Fund “A way to make Europe”/“Investing in your future”)”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.